Form 8-K - Current report:
SEC Accession No. 0000950170-25-035909
Filing Date
2025-03-10
Accepted
2025-03-10 07:10:34
Documents
13
Period of Report
2025-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dsgn-20250310.htm   iXBRL 8-K 48133
2 EX-99.1 dsgn-ex99_1.htm EX-99.1 153091
3 GRAPHIC img267412975_0.jpg GRAPHIC 107166
  Complete submission text file 0000950170-25-035909.txt   478157

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dsgn-20250310.xsd EX-101.SCH 26968
15 EXTRACTED XBRL INSTANCE DOCUMENT dsgn-20250310_htm.xml XML 5111
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40288 | Film No.: 25722132
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)